Skip to main content

Volume 1 Supplement 1

Abstracts of the 28th Annual Scientific Meeting of the Society for Immunotherapy of Cancer (SITC)

Immunotherapy targeting esophageal cancer stem cells

Esophageal cancer is one of most common malignancies. Cancer stem cells (CSC) are considered to be resistant to chemotherapy and radiotherapy, which might be associated with the recurrence of the tumor after treatment. To find the therapeutic procedures targeting CSCs, the different methods have been used to identify the esophageal CSC-related genes and surface markers. The esophageal CSCs were found to resist the chemotherapy and the mechanism was explored as well. We also found the levels of tumor associated antigens in esophageal CSCs have differences comparing with the non-stem cancer cells. To understand if the tumor associated antigens can be used as targets by immune cells, we cloned the tumor antigen specific T cells and analyzed the T cell recognition of esophageal CSC both in vitro and in vivo. We found that the immunotherapy might be one of the optimal procedures targeting both non-stem cancer cells and esophageal CSC.

Author information



Corresponding author

Correspondence to Yi Zhang.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Yue, D., Ren, H., Huang, L. et al. Immunotherapy targeting esophageal cancer stem cells. j. immunotherapy cancer 1, P178 (2013).

Download citation


  • Public Health
  • Cancer Cell
  • Stem Cell
  • Immune Cell
  • Esophageal Cancer